MONTREAL--(BUSINESS WIRE)--March 3, 2005--MDS Pharma Services
(NYSE:MDZ)(TSX:MDS), a leading provider of innovative drug discovery
and development solutions, will host a grand opening event for its
newly expanded Singapore facility. This expansion houses MDS Pharma
Services' growing presence in Singapore, which currently includes
central lab and ECG study coordination services, logistics and global
clinical development services. Keynote speaker for the grand opening
program will be Andy Lee, Senior Director, Cardiovascular and
Metabolic Diseases, Pfizer Global Research and Development, who will
discuss "The Global Nature of Clinical Trials: Emergence of Asia as a
Key Player."
WHAT: Grand opening ceremony for MDS Pharma Services' expanded
Singapore facility including ribbon-cutting ceremony,
lab tours, gala dinner and keynote speaker
WHEN: Monday, April 11, 2005
Press Conference at 2:30 PM
WHERE: 2 International Business Park
#10-06, Tower 1, The Strategy
Singapore 609930
Individuals interested in attending this grand opening event are
encouraged to view the complete agenda online at
www.mdsps.com/events/singapore2005.htm. Registration is available on
that Web page or via e-mail at Singapore.launch@mdsps.com.
MDS Pharma Services offers a full spectrum of resources to meet
the drug discovery and development needs of the pharmaceutical and
biotechnology industries. With numerous facilities strategically
located around the world, the company applies advanced scientific and
technological expertise to each stage of the drug discovery and
development process - early stage: lead optimization, pre-IND
research, pharmaceutical and biopharmaceutical development, early
clinical research (bioequivalence, phases I-IIa) and bioanalysis; and
late stage: global clinical development (phases IIb-IV) and central
lab. For more information, visit MDS Pharma Services' Web site at
www.mdsps.com.
MDS Pharma Services is an integral part of MDS Inc.
(TSX:MDS)(NYSE:MDZ). MDS Inc. has more than 9,000 highly skilled
people in 25 countries providing a diverse range of superior products
and services to increase our customers' speed, precision and
productivity in the drug development and disease diagnosis processes.
We are a global health and life sciences company, recognized for our
reliability and collaborative relationships. Please refer to our
website at www.mdsintl.com to find out more about how we help create
better outcomes in the treatment of disease.
For further information regarding the event, please contact
Raymond Yeung, MDS Pharma Services, 2 International Business Park,
#10-06, Tower 1, The Strategy, Singapore 609930, Tel: +65-6896-5301.
CONTACT: MDS Pharma Services
For Media Inquiries:
Kim Peacock
(402) 476-2811
621 Rose Street, Lincoln Neb.
www.mdsps.com
SOURCE: MDS Pharma Services
|